Blood News and Research

RSS

Common biomarker of kidney disease may also indicate COPD

A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

28 Sep 2018

Exploring factors that need considered before offering genetic risk information to individuals

Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.

28 Sep 2018

High levels of fibroblast growth factor 23 may affect brain health

Scientists at the Medical University of South Carolina have uncovered mechanisms by which high levels of a hormone called FGF23 can reduce brain health.

28 Sep 2018

Researchers develop unique, biofuel-powered sensor to prevent and diagnose diseases

Researchers at Washington State University have developed an implantable, biofuel-powered sensor that runs on sugar and can monitor a body's biological signals to detect, prevent and diagnose diseases.

28 Sep 2018

Genetic score helps predict future major coronary events, shows study

Coronary artery disease (CAD) is the leading killer of people with type 2 diabetes, and it's not a secret killer.

28 Sep 2018

Broadly neutralizing antibodies offer a new approach to treating HIV infection

A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection.

28 Sep 2018

Critical illness and major infection can promote brain changes, accelerate cognitive decline

Researchers at Johns Hopkins report that a novel analysis of more than a thousand patients adds to evidence that hospitalization, critical illness and major infection may diminish brain structures that are most commonly affected by Alzheimer's disease.

28 Sep 2018

Researchers find a novel way to tease out key factor involved in heart muscle maturation

Scientists around the world have been trying to replace damaged heart tissue using lab-made heart-muscle cells (cardiomyocytes), either injecting them into the heart or applying patches laced with the cells. But results to date have been underwhelming.

28 Sep 2018

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected by Verastem OncologyTM to dispense COPIKTRA (duvelisib) capsules.

28 Sep 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Diet comprising of soups and shakes may combat obesity

According to a new study a diet comprising of soups and shakes replacing regular food could help people with obesity to lose weight significantly and sustain it over time.

27 Sep 2018

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

According to a new study women of reproductive age who are using the modern oral contraceptive pills or patches and rings that contain a combination of estrogen and progesterone are at a reduced risk for ovarian cancer. The study was published in the recent issue of the British Medical Journal (BMJ).

27 Sep 2018

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, as part of the agency's Small Business Innovation Research Program.

27 Sep 2018

Henry Ford Hospital cardiologists are first in the U.S. to implant device for hard-to-treat angina

Cardiologists at Henry Ford Hospital performed the first implantation in the United States of a device approved for use in Europe for hard-to-treat angina.

27 Sep 2018

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.

27 Sep 2018

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.

27 Sep 2018

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

OrthoSera GmbH, an orthobiologics company developing serum-based solutions for musculoskeletal indications announces results of its first-in-man pilot clinical study of hyperacute serum on 36 patients in knee osteoarthritis.

27 Sep 2018

Novel therapy technique double rate of upper limb recovery in stroke patients

A novel therapy technique invented by researchers at The University of Texas at Dallas has been shown in a pilot study to double the rate of upper limb recovery in stroke patients, a leap forward in treating the nearly 800,000 Americans who suffer strokes each year.

27 Sep 2018

EU conducts research into mechanisms and effects of atrial fibrillation

Atrial fibrillation is the most common type of irregular heartbeat, or cardiac arrhythmia, affecting 2-3 % of the European population and as many as one in 10 people over the age of 80.

27 Sep 2018

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

For patients diagnosed with a Staphylococcus aureus infection, often referred to as a staph or MRSA infection, every minute counts.

27 Sep 2018

Blood News and Research

Common biomarker of kidney disease may also indicate COPD

Exploring factors that need considered before offering genetic risk information to individuals

High levels of fibroblast growth factor 23 may affect brain health

Researchers develop unique, biofuel-powered sensor to prevent and diagnose diseases

Genetic score helps predict future major coronary events, shows study

Broadly neutralizing antibodies offer a new approach to treating HIV infection

Critical illness and major infection can promote brain changes, accelerate cognitive decline

Researchers find a novel way to tease out key factor involved in heart muscle maturation

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Diet comprising of soups and shakes may combat obesity

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

Henry Ford Hospital cardiologists are first in the U.S. to implant device for hard-to-treat angina

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

Novel therapy technique double rate of upper limb recovery in stroke patients

EU conducts research into mechanisms and effects of atrial fibrillation

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News